Cordlife records fourth consecutive quarter of revenue growth
Cord blood and tissue banking service provider Cordlife recorded its fourth consecutive quarter of revenue growth since listing in March last year.
The company reported a 192.7 per cent rise in net profit to $5.6 million for the three months ended Dec 31, compared to $1.9 million for same period the year before.
The company also reported a 23.9 per cent increase in revenue to $8.8 million, which was driven by an increase in the number of client deliveries.
It also recorded a one-time disposal gain of $2.7 million from the disposal of its 10 per cent interest in China Stem Cells (South) Company.